Aurinia Pharmaceuticals
AUPH
AUPH
68 hedge funds and large institutions have $108M invested in Aurinia Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 17 increasing their positions, 15 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
68
Holders Change
+6
Holders Change %
+9.68%
% of All Funds
1.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
17
Reduced
15
Closed
14
Calls
$865K
Puts
$2.99M
Net Calls
-$2.12M
Net Calls Change
+$1.29M
Top Buyers
| 1 |
1
BlackRock
New York
|
$3.26M |
| 2 |
PC
2
Polar Capital
London,
United Kingdom
|
$10.4M |
| 3 |
3
Point72 Asset Management
Stamford,
Connecticut
|
$2.43M |
| 4 |
4
Franklin Resources
San Mateo,
California
|
$7.54M |
| 5 |
5
Goldman Sachs
New York
|
$5.41M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
76
Barclays
London,
United Kingdom
| – | -$120K | -19,100 | Closed |
|
|
NAM
77
NTV Asset Management
Charleston,
West Virginia
| – | -$94K | -15,000 | Closed |
|
|
BFM
78
Boothbay Fund Management
New York
| – | -$80K | -12,726 | Closed |
|
79
Jane Street
New York
| – | -$63K | -10,041 | Closed |
|
|
NIT
80
NumerixS Investment Technologies
Vancouver,
British Columbia, Canada
| – | -$29K | -4,600 | Closed |
|
|
FPF
81
FNY Partners Fund
New York
| – | -$18K | -3,000 | Closed |
|
|
AG
82
Advisor Group
Phoenix,
Arizona
| – | -$3K | -500 | Closed |
|